Recap: June was packed with new updates!.We were at ASCO – from groundbreaking presentations to the latest FDA approvals. Swipe through for a fast-track overview of clinical highlights, fresh data, and key milestones!. #ASCO #Oncology #CancerResearch #ClinicalTrials

The latest in Rheumatology on our sister website Watch the #EULAR2025 highlight summaries by Xenofon Baraliakos, MD, the new President of the European Alliance of Associations for Rheumatology and discover study updates in Axial spondyloarthritis: BE

RCC updates from #ASCO25 are live on high5oncologyTV 🧬 Summarized in 100 seconds and thoroughly discussed by experts: . @nachoduranm @GoebellJ @HHammersMD @IvanyiPhilipp @montypal @brian_rini . #KidneyCancer #RCC #RenalCellCarcinoma #ASCO2025

May 2025 Highlights: New studies, updated clinical guidelines, and key takeaways from the ESPE Congress. Swipe through the most important insights – compact, clear and at a glance. #HealthProfessionals #MedicalNews #InCaseYouMissedIt #HormoneHealth.#ESPE2025 #ClinicalGuidelines

NSCLC, SCLC & more – expert videos on demand 🎥 .. #LungCancer #NSCLC #SCLC #ASCO2025 #ImmunoOncology #TargetedTherapy #CancerUpdates #high5oncologyTV #OncologyResearch #PDL1 . @StephenVLiu @DrRiyazShah @GriesingerFrank @MartinReck2 @NReguart

IO, ADCs, real-world impact – watch the key trials now discussed by experts at high5oncologyTV: . @OncoBellmunt @scserendipity1 @GoebellJ @PGrivasMDPhD @IvanyiPhilipp @y_loriot @tompowles1 . #BladderCancer #UrothelialCancer #ASCO2025 #GenitourinaryCancer

Breast cancer at ASCO 2025 – top trials, expert takes 👉 high5oncologyTV: . @E_de_Azambuja @evaciruelos @JavierCortesMD @curijoey @RebeccaDSing @ALEDIGNUS12 @DLueftner @volkmar_mueller @BarbaraPistill2 @hoperugo @stolaney1

Watch the updates that matter: prostate cancer insights - discussed by experts and explained in minutes: . @bjartell @scserendipity1 @EfstathiouEleni @grimm_mo @amerseburger @weoncologists @declangmurphy @nealshore @OncoAlert

🫁 Lung cancer spotlight at #ASCO25!.Huge thanks to @StephenVLiu, @GriesingerFrank, Michael Thomas, @DrRiyazShah, @HosseinBorghei, @HendriksLizza, @NReguart, @nicogirardcurie for sharing key updates. 👉Visit us at high5oncologyTV:

RT @OncoAlert: Check out these Great video links from our Collaborators at @high5md straight from #ASCO25. *GU oncology*.CREST. https://t.co….

Missed ASCO? Get the key insights now – fast & free 👉 high5oncologyTV: . @StephenVLiu @DrRiyazShah @GriesingerFrank @MartinReck2 @NReguart @HendriksLizza @nicogirardcurie @DMSLung @HosseinBorghaei @OncoBellmunt.@bjartell @scserendipity1 @nachoduranm

April 2025 Recap – New Studies & Guideline Updates. Swipe through for a compact summary of the key insights. for more Informations: .👉 .👉 .👉 .👉 . #FDAapproval #HCC #Immunotherapy

Our sister page high5endocrinologyTV is online with the latest reports from ESPE/ESE 2025 in Copenhagen. Many thanks to Diego Ferone, MD, one of our experts, who summarises the latest in pituitary and neuroendocrinology! For more information on diabetes, obesity, thyroid,

Meet the ESE/ESPE Congress 2025 experts from our sister site Heide Siggelkow, MD – Roland Pfäffle, MD – Dagmar Führer-Sakel, MD – Jörg Oliver Semler, MD – Diego Ferone, MD – Tommaso Aversa, MD – María Jesús Chueca Guindulain, MD – Paul W. Franks, PhD

ESPE/ESE 2025 in Copenhagen – here we go! 🇩🇰✨ Discover all the highlights from the ESPE/ESE 2025 endocrinology congress at our sister company Check it out for on-site coverage from experts from May 13th!.#espe2025 #ese2025 #denmark #copenhagen

February Recap – A month full of valuable insights!.In February, we attended the following conferences:.👉 ASCO GU 2025: Learn more here! .👉 ECCO 2025: Find more details here! .Stay tuned – the journey continues!. #high5 #oncology

ASCO GU 2025 – Stay Ahead in Uro-Oncology.Time is precious – so is knowledge. Get the essential updates from ASCO GU 2025 in just 100 seconds and in in-depth expert discussions with high5oncologyTV!. ✔ Fast: Key takeaways, delivered concisely. ✔ Expert-Led: Leading specialists

Bladder Cancer: ASCO GU 2025 in Just 100 Seconds! .What’s new in bladder cancer research?. 🔬 Key trial results on novel therapies and emerging treatment strategies. 🩺 Expert discussions on how these updates impact clinical practice. ⏱️ 100-Second Summaries – fast, insightful,

💡 ASCO GU 2025: What’s Next for Prostate Cancer Treatment? .Major studies. Expert opinions. Clinical relevance. high5oncologyTV delivers:.✔ 100-Second Key Takeaways – fast, focused, and evidence-based. ✔ Deep-Dive Panels on the most practice-changing prostate cancer data. ✔

Live now on Expert insights from #ECCO2025!.🔗 A big thank you to Peter Irving, MD, for sharing the latest findings on #IBD, #CrohnsDisease, #UlcerativeColitis, #Immunology, and more. 📢 Don’t miss out — watch the key takeaways